Design and discovery of soluble epoxide hydrolase inhibitors for the treatment of cardiovascular diseases-Reference-Cited by-同舟云学术

Design and discovery of soluble epoxide hydrolase inhibitors for the treatment of cardiovascular diseases

Published:2014-02-04 Issue:3 Volume:9 Page:229-243
ISSN:1746-0441
Container-title:Expert Opinion on Drug Discovery
language:en
Short-container-title:Expert Opinion on Drug Discovery

Author:

Duflot Thomas¹²,Roche Clothilde²,Lamoureux Fabien¹,Guerrot Dominique³²,Bellien Jeremy¹²

Affiliation:

1. Rouen University Hospital, Department of Pharmacology, Rouen, France

2. University of Rouen, Institut National de la Santé et de la Recherche Médicale (INSERM) U1096, Institute for Research and Innovation in Biomedicine, Rouen Cedex, 76031, France ; ;

3. Rouen University Hospital, Department of Nephrology, Rouen, France

Publisher

Informa Healthcare

Subject

Drug Discovery

Link

https://www.tandfonline.com/doi/pdf/10.1517/17460441.2014.881354

Reference104 articles.

1. Impact of Soluble Epoxide Hydrolase and Epoxyeicosanoids on Human Health

2. Modulation of cytochrome-derived epoxyeicosatrienoic acids pathway: A promising pharmacological approach to prevent endothelial dysfunction in cardiovascular diseases?

3. Epoxides and Soluble Epoxide Hydrolase in Cardiovascular Physiology

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Soluble epoxide hydrolase: an emerging target for nutraceuticals against inflammation and oxidative stress;Current Opinion in Food Science;2024-06

2. 1,3-Dichloroadamantyl-Containing Ureas as Potential Triple Inhibitors of Soluble Epoxide Hydrolase, p38 MAPK and c-Raf;International Journal of Molecular Sciences;2023-12-26

3. Synthesis of some piperazine/piperidine amides of chromone-2-carboxylic acid as potential soluble epoxide hydrolase (sEH) inhibitors;Organic Communications;2023-03-30

4. Benzoxazolone-5-Urea Derivatives as Human Soluble Epoxide Hydrolase (sEH) Inhibitors;ACS Omega;2023-01-04

5. Soluble epoxide hydrolase inhibitor, t-AUCB, improves salivary gland function by ameliorating endothelial injury;Life Sciences;2022-11